Psychedelic Stocks,Trends & Articles COMPASS Granted Two New Patents in the United States By Dennis Mutua March 24, 2021 UK based mental health care company COMPASS Pathway PLC. (NASDAQ: CMPS) announced having been granted two new patents by the US Patent and Trademark Office. These patents are for oral formulations of synthetic psilocybin develo...
Shroom News,Spotlight Stock Numinus Leading in Developing and Delivering of Psychedelic Assisted Psychotherapies By Dennis Mutua March 24, 2021 Mental health and wellness company Numinus Wellnes Inc. (CVX: NUMI) parades itself as a market leader in in developing and delivering safely psychedelic-assisted psychotherapies. The company bases its operational model from these ...
Spotlight Stock,Trends & Articles Cyblin Inks Drug Development Agreement With Catalent For its Deuterated Tryptamine By Dennis Mutua March 23, 2021 Biotech company specializing on progressing psychedelic therapeutics Cybin Inc. (OTCMKTS: CLXPF) has inked a drug development agreement deal with New Jersey based Catalent Inc. (NYSE: CTLT) for its Deuterated Tryptamine (CYB003)....
Featured,Psychedelic Stocks Mindset Pharma Enters Deal With Canaccord as Lead Underwriter in $5 Million Financing Deal By Dennis Mutua March 23, 2021 Mindset Parma Inc. (CNSX: MSET) (OTCQB: MSSTF) announced having entered into a financing deal with financial service provider company Canaccord Genuity Group Inc. (TSE:CF) in which Canaccord will be its lead underwriter in a $5,00...
Psychedelic Stocks Pure Extract Orders New State of Art Cosolvent Injection System By Dennis Mutua March 22, 2021 Plant based extraction company Pure Extract Technology Group (CNSX: PULL) (OTC: PRXTF) has ordered the extraction of a new state-of-the-art Cosolvent Injection System (CIS) from world leading manufacturer of scalable CO2 Vitalis E...
Shroom News Australia Sets Aside $15 Million to Aid in Psychedelics Studies By Dennis Mutua March 22, 2021 Australia’s federal government announced having set aside a grant of $15 million to assist in the study of psychedelics. The government says this cash will help in studying the use of psychedelic drugs including ecstasy and mush...
Psychedelic Stocks,Trends & Articles Cedar Picked to Partner with Merck on Trials of Treatment Resistant Depression Drug By Dennis Mutua March 19, 2021 Novamind Inc. (CNSX:NM)(OTC PINK:NVMDF) wholly owned subsidiary Cedar Clinical Research (CCR) has been selected to partner with leading pharmaceutical company Merck & Co Inc. (MRK) in clinical trial focusing on new treatment-...
Featured,Shroom News Tryp Files for Provisional Patent for Improved Administration of Psychedelics By Dennis Mutua March 19, 2021 Tryp Therapeutics (CNSX: TRYP) announced having filed for a provisional patent for improved administration of Psychedelics. The patent describes the improved methods for formulation, delivery and dosing of psychedelics. The fi...
